 Cyclic N-Oxides
"Cyclic N-Oxides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Heterocyclic compounds in which an oxygen is attached to a cyclic nitrogen.
| Descriptor ID |
D003497
|
| MeSH Number(s) |
D03.661.243
|
| Concept/Terms |
Cyclic N-Oxides- Cyclic N-Oxides
- N-Oxides, Cyclic
- Cyclic N Oxides
- N Oxides, Cyclic
- Oxides, Cyclic N
- Heterocyclic N-Oxides
- Heterocyclic N Oxides
- N-Oxides, Heterocyclic
|
Below are MeSH descriptors whose meaning is more general than "Cyclic N-Oxides".
Below are MeSH descriptors whose meaning is more specific than "Cyclic N-Oxides".
This graph shows the total number of publications written about "Cyclic N-Oxides" by people in UAMS Profiles by year, and whether "Cyclic N-Oxides" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 | | 2015 | 0 | 2 | 2 | | 2013 | 1 | 0 | 1 | | 2009 | 1 | 1 | 2 | | 2006 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Cyclic N-Oxides" by people in Profiles over the past ten years.
-
Paudel NR, Shvydka D, Parsai EI. A novel property of gold nanoparticles: Free radical generation under microwave irradiation. Med Phys. 2016 Apr; 43(4):1598.
-
Stec DE, Juncos LA, Granger JP. Renal intramedullary infusion of tempol normalizes the blood pressure?response to intrarenal blockade of heme oxygenase-1 in?angiotensin II-dependent hypertension. J Am Soc Hypertens. 2016 Apr; 10(4):346-51.
-
Alagpulinsa DA, Ayyadevara S, Yaccoby S, Shmookler Reis RJ. A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition. Mol Cancer Ther. 2016 Feb; 15(2):241-50.
-
Li L, Pongtornpipat P, Tiutan T, Kendrick SL, Park S, Persky DO, Rimsza LM, Puvvada SD, Schatz JH. Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1. Leukemia. 2015 Aug; 29(8):1702-12.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|